Combined molnupiravir-nirmatrelvir treatment improves the inhibitory effect on SARS-CoV-2 in macaques

Combined molnupiravir-nirmatrelvir treatment improves the inhibitory effect on SARS-CoV-2 in macaques

The periodic emergence of SARS-CoV-2 variants of concern (VOCs) with unpredictable clinical severity and ability to escape preexisting immunity emphasizes the continued need for antiviral interventions. Two small molecule inhibitors, molnupiravir (MK-4482), a nucleoside analog, and nirmatrelvir (PF-...

ver descrição completa

Detalhes bibliográficos
Main Authors: Kyle Rosenke, Matt C. Lewis, Friederike Feldmann, Eric Bohrnsen, Benjamin Schwarz, Atsushi Okumura, W. Forrest Bohler, Julie Callison, Carl Shaia, Catharine M. Bosio, Jamie Lovaglio, Greg Saturday, Michael A. Jarvis, Heinz Feldmann
Formato: Artigo
Idioma:English
Publicado em: American Society for Clinical investigation 2023-02-01
Colecção:JCI Insight
Assuntos:
COVID-19
Acesso em linha:https://doi.org/10.1172/jci.insight.166485

Internet

https://doi.org/10.1172/jci.insight.166485

Registos relacionados